<DOC>
	<DOCNO>NCT01133301</DOCNO>
	<brief_summary>Our study aim contribute valid appraisal magnitude naltrexone efficacy antidissociative agent use double-blind randomize controlled trial .</brief_summary>
	<brief_title>Naltrexone Treatment Dissociative Symptoms Patients With Borderline Personality Disorder</brief_title>
	<detailed_description>Patients randomize two group start either 3 week 50 mg/d naltrexone 3 week placebo . In either case active treatment phase ( week 1-6 ) follow one week placebo . The major purpose week 1-2 4-5 , respectively , achieve steady state active treatment . The primary comparison psychopathology naltrexone placebo refer week follow intended achievement steady state ( week 3 6 , respectively ) . 6 week treatment split two phase : ( A ) 3 week pharmacologically active treatment naltrexone ( B ) 3 week pharmacologically inactive treatment placebo ( cross-over design ) . The sequence two treatment phase randomize concealed patient health care professional . In case , last week ( `` Week 7 '' ) without pharmacological intervention . The primary outcome base DSS , reliable valid self-rating instrument ass dissociative experience inner tension last 24 hour ( Stiglmayr et al . 2001 ) Mean score intensity ( range 0= '' '' 9= '' strong '' ) duration ( average time particular symptom present last 24 hour ( % ) ) calculate ( ) dissociation ( calculated 21 Likert type item ) ( b ) aversive inner tension ( one item ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Diagnosis BPD accord DSMIV DES score â‰¥ 18 Female gender Age 18 50 year Lifetime diagnosis schizophrenia , psychotic delusional disorder Current major depressive episode Lifetime diagnosis opioid dependence Current diagnosis opioid abuse Liver insufficiency hepatitis Other major medical neurological medical condition Pregnancy lactation Psychotropic medication within two week trial ( fluoxetine 4 week , lithium 8 week ) Concomitant treatment opioid analgetics Hypersensitivity naltrexone</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Borderline Personality Disorder</keyword>
	<keyword>Dissociation</keyword>
	<keyword>Naltrexone</keyword>
</DOC>